Additional Information
Market: AIM
Sector: Pharmaceuticals & Biotechnology
EPIC: PIM
Latest Price: 13.50p  (-1.82% Descending)
52-week High: 35.25p
52-week Low: 13.50p
Market Cap: 6.81M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Plant Impact
www.plantimpact.com

Plant Impact's range of crop nutrition products focus on crop enhancement. They improve crop performance and crop health giving growers increased marketable yields, better quality and longer shelf life with reduced environmental impact.

Pdf

Plant Impact poised for push into US market via Arysta partnership

15th Dec 2011, 8:39 am by Andre Lamberti Plant Impact expects to grow its business in the 2012 calendar year into the US turf market via its strategic partnership with Arysta LifeScience, targeting the golf course market there

Plant Impact PLC (LON:PIM) said apart from its continued focus in the "near" markets of the UK, Netherlands, France and Germany,  it also expects to grow its business in the 2012 calendar year into the US turf market via its strategic partnership with Arysta LifeScience, targeting the golf course market there.

The comments came as the company, which develops and markets crop yield enhancing products, reported its results for the six months to September 30 2011.

During the period, in May, Arysta took a 9.1 percent stake in the company at a significant premium to the share price and in August, Arysta veteran John Brubaker took over the helm as Plant Impact chief executive.

Arysta injected £2.1 million into the group through the share subscription, of which £1 million was earmarked for development work on its turf and ornamental market in the US and the horticultural market in Brazil.

Gardens, golf courses and outfield turf management represent major potential markets for PiNT, a nitrogen product that is eco-friendly and improves plant growth by helping turf grass retain nitrogen for longer.

Turnover in the first half dipped to £610,042 from £638,409 a year earlier, primarily due to the seasonality and timing of purchases from customers in the Netherlands.  All other regions of Plant Impact's business showed consistent or improved sales performance year-on-year.

The group widened its operating loss to £1.49 million from £1.16 million a year earlier, mainly due to higher research and development costs in relation to the planned push into the US and Brazil markets.

Since early September, the board has examined the operating expense base carefully and has identified many activities that were consuming cash but not serving to accelerate the new measured-growth strategy. 

These activities and associated costs have been eliminated and include public relations expenses, travel expenses - reduced significantly due to the focus on "near" markets -, certain R&D costs, general office expenses and various legal and professional costs.

Plant Oil also eliminated some staffing costs through combining several positions and roles, at the same time identifying the need to strengthen certain areas.  “As a result, we are now actively recruiting for new staff in marketing, supply chain, and finance.” 

“We expect the financial, operational and strategic benefits from the actions described above to arise in 2012 and beyond,” the company added.

The roll-out of products in the US market will be slightly later than planned.  Management decided to delay entry into that market until resources permit and launches can be planned in detail to ensure a good likelihood of success.

This means that previosuly expected revenues from the US may not be achieved prior to the end of the financial year to March 31 2012.  Plant Impact is therefore lowering its revenue forecast for the full year to between £1.8 million and £2.2 million from around £2.8 million expected previously.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.